DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

The company's plans to expand its restructuring efforts have received mixed reactions from industry analysts and stakeholders. Some have praised the company for taking bold and decisive actions to address its financial challenges and position itself for growth, while others have criticized the layoffs as short-sighted and potentially damaging to the company's reputation and employee morale.As the Israeli forces continue their advance towards Damascus, the situation remains fluid and unpredictable. The potential for direct confrontation between Israel and Syria, as well as the risk of wider regional conflict, looms large. The coming days will be crucial in determining the course of action and the prospects for a peaceful resolution to the crisis.